who make tirzepatide Mounjaro vs. Compounded — they may share the same active ingredient, but they are NOT the same. Understanding the difference is key when it comes to safety, effectiveness, and consistency. Mounjaro FDA approves new weight loss
Description
TEXT ON-SCREEN: ,
Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, designed to enhance glycemic control in patients with type 2 diabetes

Pharmaceutical giant Eli Lilly said it plans to seek approval for the drug in the US for managing obesity and UK submission will follow after it found those on the drug achieved average weight reductions of 13.4 per cent

Both use the same 5-days-on/2-days-off schedule, making them naturally synchronized

doi: 10.1097/CRD.0000000000000351 [DOI] [PubMed] [Google Scholar] 9

Those whose weight gain came more from portion size than from constant snacking still respond well, but the change can feel more gradual
